1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    





























































































































    Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleAdult Brain

  
      
Open Access

  
      
Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma
  
    	
I.E. Chen, N. Swinburne, N.M. Tsankova, M.M. Hefti, A. Aggarwal, A.H. Doshi, A. Hormigo, B.N. Delman and K. Nael

  
    	
American Journal of Neuroradiology June 2018,  39 (6) 1039-1046; DOI: https://doi.org/10.3174/ajnr.A5639 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
REFERENCES
  1. 1.↵
    1. 

    2. Delgado-López  PD, 
    3. Corrales-García  EM, 
    4. Martino  J, et al
    . Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol 2017;19:931–44 doi:10.1007/s12094-017-1631-4 pmid:28255650
    CrossRefPubMed
  2. 2.↵
    1. 

    2. Larsen  J, 
    3. Wharton  SB, 
    4. McKevitt  F, et al
    . ‘Low grade glioma’: an update for radiologists. Br J Radiol 2017;90:20160600 doi:10.1259/bjr.20160600 pmid:27925467
    CrossRefPubMed
  3. 3.↵
    1. 

    2. Nahed  BV, 
    3. Redjal  N, 
    4. Brat  DJ, et al
    . Management of patients with recurrence of diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2015;125:609–30 doi:10.1007/s11060-015-1910-2 pmid:26530264
    CrossRefPubMed
  4. 4.↵
    1. 

    2. van den Bent  MJ, 
    3. Wefel  JS, 
    4. Schiff  D, et al
    . Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 2011;12:583–93 doi:10.1016/S1470-2045(11)70057-2 pmid:21474379
    CrossRefPubMedWeb of Science
  5. 5.↵
    1. 

    2. Fouke  SJ, 
    3. Benzinger  T, 
    4. Gibson  D, et al
    . The role of imaging in the management of adults with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2015;125:457–79 doi:10.1007/s11060-015-1908-9 pmid:26530262
    CrossRefPubMed
  6. 6.↵
    1. 

    2. Asari  S, 
    3. Makabe  T, 
    4. Katayama  S, et al
    . Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 1994;36:308–10 doi:10.1007/BF00593267 pmid:8065577
    CrossRefPubMed
  7. 7.↵
    1. 

    2. Kim  MM, 
    3. Lawrence  TS, 
    4. Cao  Y
    . Advances in magnetic resonance and positron emission tomography imaging: assessing response in the treatment of low-grade glioma. Semin Radiat Oncol 2015;25:172–80 doi:10.1016/j.semradonc.2015.02.003 pmid:26050587
    CrossRefPubMed
  8. 8.↵
    1. 

    2. Pallud  J, 
    3. Capelle  L, 
    4. Taillandier  L, et al
    . Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 2009;11:176–82 doi:10.1215/15228517-2008-066 pmid:18697954
    CrossRefPubMed
  9. 9.↵
    1. 

    2. Vos  MJ, 
    3. Uitdehaag  BM, 
    4. Barkhof  F, et al
    . Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology 2003;60:826–30 doi:10.1212/01.WNL.0000049467.54667.92 pmid:12629241
    Abstract/FREE Full Text
  10. 10.↵
    1. 

    2. Hayashida  Y, 
    3. Hirai  T, 
    4. Morishita  S, et al
    . Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006;27:1419–25 pmid:16908550
    Abstract/FREE Full Text
  11. 11.↵
    1. 

    2. Chenevert  TL, 
    3. Stegman  LD, 
    4. Taylor  JM, et al
    . Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029–36 doi:10.1093/jnci/92.24.2029 pmid:11121466
    CrossRefPubMedWeb of Science
  12. 12.↵
    1. 

    2. Cui  Y, 
    3. Ma  L, 
    4. Chen  X, et al
    . Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma. J Neurooncol 2014;119:377–85 doi:10.1007/s11060-014-1490-6 pmid:24874469
    CrossRefPubMed
  13. 13.↵
    1. 

    2. Hathout  L, 
    3. Ellingson  BM, 
    4. Cloughesy  TF, et al
    . Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growth. Oncol Rep 2015;33:2883–88 doi:10.3892/or.2015.3926 pmid:25962999
    CrossRefPubMed
  14. 14.↵
    1. 

    2. Kitis  O, 
    3. Altay  H, 
    4. Calli  C, et al
    . Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55:393–400 doi:10.1016/j.ejrad.2005.02.004 pmid:16129247
    CrossRefPubMed
  15. 15.↵
    1. 

    2. Murakami  R, 
    3. Hirai  T, 
    4. Sugahara  T, et al
    . Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 2009;251:838–45 doi:10.1148/radiol.2513080899 pmid:19318585
    CrossRefPubMedWeb of Science
  16. 16.↵
    1. 

    2. Hein  PA, 
    3. Eskey  CJ, 
    4. Dunn  JF, et al
    . Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004;25:201–09 pmid:14970018
    Abstract/FREE Full Text
  17. 17.↵
    1. 

    2. Higano  S, 
    3. Yun  X, 
    4. Kumabe  T, et al
    . Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006;241:839–46 doi:10.1148/radiol.2413051276 pmid:17032910
    CrossRefPubMedWeb of Science
  18. 18.↵
    1. 

    2. Brasil Caseiras  G, 
    3. Ciccarelli  O, 
    4. Altmann  DR, et al
    . Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 2009;253:505–12 doi:10.1148/radiol.2532081623 pmid:19789244
    CrossRefPubMedWeb of Science
  19. 19.↵
    1. 

    2. Chenevert  TL, 
    3. Malyarenko  DI, 
    4. Newitt  D, et al
    . Errors in quantitative image analysis due to platform-dependent image scaling. Transl Oncol 2014;7:65–71 doi:10.1593/tlo.13811 pmid:24772209
    CrossRefPubMed
  20. 20.↵
    1. 

    2. Kang  Y, 
    3. Choi  SH, 
    4. Kim  YJ, et al
    . Gliomas: histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging–correlation with tumor grade. Radiology 2011;261:882–90 doi:10.1148/radiol.11110686 pmid:21969667
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. 

    2. Wen  Q, 
    3. Jalilian  L, 
    4. Lupo  JM, et al
    . Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol 2015;121:331–39 doi:10.1007/s11060-014-1636-6 pmid:25351579
    CrossRefPubMed
  22. 22.↵
    1. 

    2. McDonald  CR, 
    3. Delfanti  RL, 
    4. Krishnan  AP, et al
    . Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma. Neuro Oncol 2016;18:1579–90 doi:10.1093/neuonc/now063 pmid:27106406
    CrossRefPubMed
  23. 23.↵
    1. 

    2. Cha  S
    . Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–87 pmid:16551981
    FREE Full Text
  24. 24.↵
    1. 

    2. Tozer  DJ, 
    3. Jäger  HR, 
    4. Danchaivijitr  N, et al
    . Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed 2007;20:49–57 doi:10.1002/nbm.1091 pmid:16986106
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. 

    2. Jung  SC, 
    3. Choi  SH, 
    4. Yeom  JA, et al
    . Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods. PLoS One 2013;8:e69323 doi:10.1371/journal.pone.0069323 pmid:23950891
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma
  
    	
I.E. Chen, N. Swinburne, N.M. Tsankova, M.M. Hefti, A. Aggarwal, A.H. Doshi, A. Hormigo, B.N. Delman, K. Nael

  
    	
 American Journal of Neuroradiology Jun 2018, 39 (6) 1039-1046; DOI: 10.3174/ajnr.A5639 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement